Displaying 4 (all) recruiting clinical trials.
-
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma Response and Biology-Based Risk factor-guided therapy in treating younger patients with non-high Neuroblastoma
This phase III trial studies how well response and biology-based risk factor-guided therapy works in treating younger patients with non-high risk neuroblastoma. Sometimes a tumor ...
Phase
Interventional
-
WUH: A phase 3 long term open-label trial investigating safety and efficacy of Transcon hGH administered once weekly in children with growth hormone deficiency (GHD) who have completed a prior Transcon hGH trial.
This is a multicenter, phase 3, long-term, open-label extension trial of weekly TransCon hGH in children with Growth Hormone Deficiency (GHD) who previously participated in ...Phase
Interventional
-
A trial comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin in children with growth hormone deficiency
Purpose of the research study is to collect information to help us understand how doctors treat and manage children and adolescent with growth hormone deficiency ...Phase
Interventional
-
A PHASE 3 OPEN-LABEL RANDOMIZED MULTICENTER 12 MONTHS EFFICACY AND SAFETY STUDY OF WEEKLY MOD-4023 COMPARED TO DAILY GENOTROPIN THERAPY IN PRE-PUBERTAL CHILDREN WITH GROWTH HORMONE DEFICIENCY
The purpose of this study is to compare the effectiveness, safety and handling of the investigational drug MOD-4023 (weekly injections, initial dose of 0.66 ...Phase
Interventional
